Global gene annotation analysis and transcriptional profiling identify key biological modules in hypoxic pulmonary hypertension.
Chronic hypoxic pulmonary hypertension is an important clinical disorder causing significant morbidity. Despite recent discoveries, many molecular mechanisms involved in its pathogenesis remain unexplored. We have undertaken a systematic and unbiased approach to gain global insights into this complex process. By combining transcriptional profiling with rigorous statistical methods and cluster analysis, we identified the dominant temporal patterns of gene expression during progression and regression of hypoxic pulmonary hypertension. We next integrated these results with global gene annotation analysis to identify key biological themes involved in the development and resolution of hypoxic pulmonary hypertension and vascular remodeling. This novel approach assigned biological roles to thousands of candidate genes based on their temporal expression profiles and membership in specific biological modules. Our procedure confirmed several molecular pathways and gene products known to be important in hypoxic pulmonary hypertension. Furthermore, we discovered several novel candidates and molecular mechanisms, including IQ motif containing GTPase-activating protein-1 (IQGAP1), decorin, insulin-like growth factor binding protein-3 (IGFBP3), and lactotransferrin, that may play crucial roles in hypoxic pulmonary hypertension and vascular remodeling. Our methodology of integrating transcriptional profiling, cluster analysis, and global gene annotation provides new insights into the pathophysiology of pulmonary hypertension and is applicable to other models of human disease.
Gharib
Sina A
SA
Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA. sagharib@u.washington.edu
Luchtel
Daniel L
DL
Madtes
David K
DK
Glenny
Robb W
RW
D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D020869:Gene Expression Profiling; D006976:Hypertension, Pulmonary / Q000150:complications / Q000235:genetics* / Q000503:physiopathology*; D000860:Hypoxia / Q000150:complications* / Q000235:genetics / Q000503:physiopathology; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000235:genetics / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D020411:Oligonucleotide Array Sequence Analysis; D011651:Pulmonary Artery / Q000503:physiopathology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014158:Transcription, Genetic / Q000235:genetics*; D018497:Ventricular Dysfunction, Right / Q000503:physiopathology
D018972:Insulin-Like Growth Factor Binding Protein 3